C[hloroquine]{.smallcaps} (CQ)^1^ has been one of the most successful antimalarial agents ever developed. Unfortunately, the emergence and spread of resistant strains of *Plasmodium falciparum* has now rendered the drug almost useless in most malaria endemic areas. The immense clinical importance of *falciparum* malaria and the universal success of CQ before the development of resistance have provided the impetus for investigations about the mode of action of CQ and the basis of resistance at the cellular level. The activity of CQ depends on a high-level accumulation within the malarial parasite and drug resistance stems from reduced drug accumulation. Unfortunately, a definitive mechanistic explanation for these observations has remained elusive ([@B14]; [@B27]; [@B21]; [@B30]; [@B8]).

However, Wünsch and co-workers recently provided compelling evidence for a novel mechanism of CQ resistance based on the differential stimulation of the parasite Na^+^/H^+^ exchanger (NHE; [@B47]). Previous work from this group linked altered saturation kinetics of initial CQ uptake to the CQ resistance phenotype ([@B36]). They found that CQ uptake was inhibited competitively by specific inhibitors of NHE, providing evidence that the drug is actively transported through the parasite NHE. They also showed that CQ stimulates the NHE of chloroquine-sensitive (CQS) parasites and suggested that CQ is taken up by the NHE of these parasites in the ensuing rapid burst of sodium--proton exchange ([@B47]). Conversely, it was proposed that the NHE of chloroquine-resistant (CQR) parasites did not transport CQ, since it was constitutively activated and insensitive to further stimulation by CQ ([@B47]). The reversal of CQ resistance by verapamil was proposed to occur by modulating the activity of parasitic NHE via the calcium/calmodulin--dependent pathway ([@B36]).

Since mammalian NHE is incapable of CQ transport ([@B36]; [@B47]), this unusual mechanism of drug uptake should be responsible for the specificity of CQ for malarial parasites. Therefore, this model is incompatible with the notion that the specificity of CQ\'s antimalarial action is caused by the formation of a drug--ferriprotoporphyrin IX (FPIX) complex accumulating in the parasite upon exposure to CQ ([@B9]; [@B15]; Balsubramanian et al., 1984; [@B41]; [@B22]). In a process unique to the malaria parasite, the FPIX released during proteolysis of hemoglobin is polymerized into an inert crystalline substance called hemozoin ([@B19]). CQ inhibits this polymerization process, causing a buildup of free FPIX and/or CQ--FPIX complex that may ultimately kill the parasite ([@B37]; [@B11]). Our own studies suggest that the specificity, accumulation, and antimalarial activity of CQ are all determined by the saturable equilibrium binding of CQ to FPIX ([@B8]).

We found that CQR parasites have a reduced apparent affinity of CQ--FPIX binding compared with CQS parasites. We propose that the resistance mechanism acts specifically at the site of FPIX generation to alter the affinity of CQ--FPIX binding rather than changing the active transport of CQ across the parasite plasma membrane ([@B8]). Here we provide definitive evidence that CQ uptake is determined by the binding of CQ to FPIX. In no part is the uptake of CQ controlled by the differential stimulation of the NHE as proposed ([@B47]). Furthermore, in CQR parasites reduced uptake of CQ, reduced apparent affinity of CQ--FPIX binding, and reversal of these parameters by verapamil are totally independent of NHE activity. We also propose a mechanistic basis for the reversal of CQ resistance in which resistance reversers increase the pH of acid vesicles where FPIX is generated. Therefore, this increases the affinity of CQ--FPIX binding.

Materials and Methods {#MaterialsMethods}
=====================

Reagents
--------

Leupeptin and trans-epoxysuccinyl-leucylamido-(4-guanidino)-butane (E64) were obtained from Boehringer Mannheim. Ro 40-4388, Ro 61-7835, and Ro 61-9379 were provided by Dr. R.G. Ridley and Dr. R. Moon of Hoffmann LaRoche. Triethylamine (TEA), diethylamine (DEA), dibutylamine (DBA), 1-methyl-piperazine (1-MP) and dipropylamine (DPA) were purchased from Aldrich Chemical Co. Silicon oil was purchased from Dow Corning. 2′,7′-bis-(2-carboxyethyl)-5,6-carboxyfluorescein-acetoxymethylester (BCECF-AM) was purchased from Molecular Probes Inc. \[^3^H\]CQ (50.4 Ci per mmol) was purchased from DuPont NEN. \[^3^H\]Hypoxanthine was purchased from Amersham and \[^3^H\]amodiaquine (AQ; 106 mCi per mmol) was synthesized in house. All other reagents were purchased from Sigma Chemical Co.

Culture of P. falciparum and Drug Sensitivity Assays
----------------------------------------------------

Parasites were cultured and synchronized using standard techniques (Trager and Jensen, 1976; Lambros and Vandenburg, 1979). Drug sensitivity in the presence or absence of potential resistance reversers and hemoglobinase inhibitors was determined according to the method of [@B10]. IC~50~ values were calculated for each assay using the four parameter logistic method (Grafit program, Erithacus software; Kent Laboratories). The effect of the combination of CQ and Ro 40-4388 on parasite growth was tested by titration of the two drugs at fixed ratios proportional to their IC~50~ values. The fractional inhibitory concentrations of the resulting IC~50~ values were plotted as isobolograms ([@B2]).

Measurement of the Effect of Proteinase Inhibitors on Parasite Hemoglobin Digestion and Parasite Hemozoin Content
-----------------------------------------------------------------------------------------------------------------

Erythrocytes infected with the K1 strain were synchronized and cultivated to the trophozoite stage and suspended in growth medium at a parasitemia of 10% and a hematocrit of 5%. At time 0, a sample was taken and the infected cells were separated, counted, and analyzed for hemoglobin and hemozoin as described below. The remaining cell suspension was incubated for 3 h at 37°C in the absence or presence of 10 μM Ro 40-4388, or 20 μM *N-*acteyl-[l]{.smallcaps}-leucyl-[l]{.smallcaps}-leucyl-methional (ALLM), or 20 μM *N-*acetyl-[l]{.smallcaps}-leucyl-[l]{.smallcaps}-leucyl-norleucinal (ALLN), or 20 μM leupeptin. After incubation, each was split into two aliquots. The infected cells from one aliquot were immediately separated from the uninfected cells using a Percoll--alanine gradient and counted as described ([@B22]). The hemoglobin and hemozoin concentrations of these cells were measured as described below. The infected cells from the remaining aliquot were washed three times in prewarmed complete medium and returned to culture for an additional 3-h incubation period. After incubation, the infected cells were separated, counted, and the hemozoin concentration was determined.

Hemoglobin concentration was measured using Drabkins reagent as described ([@B22]). The hemozoin concentration in the pellet was determined after suspension in 2% (wt/vol) SDS in 0.1 M NaHCO~3~, pH 9.1, followed by centrifugation at 14,000 rpm for 5 min. The supernatant was discarded and this step repeated three times to remove all nonhemozoin heme. The remaining hemozoin pellet was dissolved in 1 ml of 0.1 M NaOH and the absorbance was read at 400 nm using a Beckman DU640 spectrophotometer. The amount of hemozoin/10^10^ cells was calculated from a calibration curve of known amounts of FPIX dissolved in 0.1 M NaOH.

Measurement of the Uptake of \[^3^H\]CQ by Intact Parasitized Erythrocytes
--------------------------------------------------------------------------

Infected erythrocytes were suspended in the appropriate buffer containing \[^3^H\]CQ, at a parasitemia of 1--2% and a hematocrit of 0.5%. At the required times, 100-μl samples were removed and the reaction was terminated upon centrifugation of the cells (14,000 rpm for 2 min) through silicon oil and processed for scintillation counting as described in [@B7]. Parasite specific uptake was determined by subtracting counts because of an equal number of uninfected erythrocytes. Unless otherwise stated, CQ accumulation is expressed as the cellular accumulation ratio (CAR) which is the ratio of the amount of radiolabeled CQ in the parasites to the amount of radiolabeled CQ in a similar volume of buffer after incubation.

The effect of the proteinase inhibitors Ro 40-4388, Ro 61-7835, Ro 61-9379, ALLM, ALLN, leupeptin, and E64, on the steady-state uptake of CQ was measured for 1 h at 37°C, in complete medium containing 1 nM \[^3^H\]CQ. The reversibility of Ro 40-4388 (10 μM), ALLM (20 μM), and ALLN (20 μM) was determined as follows: \[^3^H\]CQ was added at a concentration of 4 nM to inhibitor-treated and control groups. After 1 h, an aliquot was taken and processed for scintillation counting as described above. The remaining aliquot was washed three times in prewarmed medium (37°C). \[^3^H\]CQ was re-introduced to the washed and control cells at a concentration of 4 nM. After 1 h, samples were removed and processed for counting. For the K1 isolate, parallel incubations were performed in the presence of 10 μM verapamil. In the case of ALLM and ALLN, inhibitors were added 45 min before the initial addition of CQ and a 10-min equilibration period was introduced after each wash.

CQ--FPIX binding parameters, in the absence or presence of 10 μM Ro 40-4388, were determined as described in [@B8]. For the K1 isolate, equilibrium binding parameters were obtained in sodium-free buffer (122.5 mM choline chloride, 5 mM KCl, 1.2 mM CaCl~2~, 0.8 mM MgCl~2~, 5.5 mM [d]{.smallcaps}-glucose, 1.0 mM K~2~HPO~4~, 10 mM Hepes, pH 7.4) in the absence or presence of 2 mM NH~4~Cl, 10 μM verapamil, or 100 nM monensin. Saturable uptake of CQ was calculated by subtracting nonsaturable CQ uptake from the total CQ uptake as described previously ([@B8]). Binding data are presented as Scatchard plots of saturable CQ uptake. The apparent *K* ~d~ of binding is given by the reciprocal of the slope and the amount of bound drug is given by the x-intercept.

The effect of resistance modulators was determined over 1 h in growth medium containing 1 nM \[^3^H\]CQ in the absence or presence of 10 μM verapamil, 100 nM nigericin, 100 nM monensin, 2 mM NH~4~Cl, 2 mM MTA, 2 mM TEA, 2 mM DEA, 2 mM DBA, 2 mM 1-MP, or 1 mM DPA. Care was taken to ensure the medium pH was 7.4 throughout. Optimum concentrations of these compounds were obtained in preliminary experiments by measuring the effect of serial 1:3 log dilutions of drugs on CQ uptake (data not shown).

To determine the effect of bicarbonate on the uptake of \[^3^H\]CQ, growth medium containing various concentrations of bicarbonate was shaken in atmospheric air at room temperature until the pH drift was complete. The pH was adjusted to 7.4 with 1 M HCl. Parasites were incubated in growth medium containing various concentrations of bicarbonate and 3 nM \[^3^H\]CQ for 1 h and terminated thereafter.

Measurement of the Uptake of \[^3^H\]CQ Into Isolated Parasites
---------------------------------------------------------------

Parasites were isolated from the host cell by selective lysis of the host cell compartment ([@B12]). Ringer\'s buffer modified to simulate an intracellular milieu was used throughout ([@B47]). In selected experiments, sodium chloride in the buffer system was replaced with molar equivalents of either choline chloride or *N*-methyl-[d]{.smallcaps}-glucamine chloride. CQ uptake was determined by suspending the cell pellet containing purified free parasites, in 200 μl of the appropriate buffer containing 50 nM \[^3^H\]CQ, prewarmed to 37°C. Drug uptake was determined in the absence or presence of 100 μM 5-*N*-ethyl-*N*-isopropyl amiloride (EIPA) or 10 μM verapamil. At the appropriate time points, aliquots were removed and the reaction was terminated by centrifugation (14,000 rpm, 1 min, at 4°C). The sample was placed in an ice-bath, the supernatant was removed, and the pellet was washed once in the appropriate ice-cold buffer without \[^3^H\]CQ. After centrifugation (14,000 rpm, 1 min, at 4°C), the supernatant was carefully removed with a drawn out glass Pasteur pipette and the pellet was processed and counted for infected erythrocytes.

CQ uptake into isolated parasites was ∼30% of intact infected erythrocytes\' uptake with over 30 min of CQ exposure. To investigate whether this reduced CQ uptake occurs because of impaired NHE activity, we compared the cytosolic pH of isolated parasites to that of parasites within intact host erythrocytes. In agreement with previous reports ([@B47]), we found no significant differences in cytosolic pH in these preparations. For example, the mean cytosolic pH for the K1 clone in its host cell was 6.902 (SEM = 0.045, *n* = 12) compared with 6.992 (SEM = 0.038, *n* = 22) when the parasite is liberated from the host cell. In addition, free parasites exhibited a marked cytosolic acidification in sodium-free buffer (0.76 pH unit ± SEM 0.045, *n* = 6), in full agreement with previous reports ([@B3]). Thus, NHE is functional in isolated parasites.

We also investigated the possibility that the reduced CQ uptake occurs because of a loss of viability. Isolated parasites were found to incorporate radiolabeled hypoxanthine and isoleucine at the same rate as intact infected erythrocytes for at least 6 h (data not shown). Since the parasites are viable and NHE is functioning normally, we assumed that the reduced accumulation of CQ happens because of cessation of hemoglobin trafficking from the host cell at time 0 that reduces the amount of FPIX available for CQ binding.

Determination of the Effect of Amiloride Analogues and Proteinase Inhibitors on FPIX Polymerization
---------------------------------------------------------------------------------------------------

Measurement of FPIX polymerization inhibition by amiloride analogues and proteinase inhibitors employed a modification of the procedure described by [@B33]. An aliquot (100 μl) of trophozoite lysate and FPIX (100 μl of 3 mM in 0.1 M NaOH) was mixed with an aliquot of 1 M HCl (10 μl) and sodium acetate (500 mM, pH 5.2) to give a volume of 900 μl in each tube. A series of drug concentrations was prepared in ethanol and 100 μl of each was added to the appropriate samples. The effect of ethanol on the polymerization process was assessed by adding 100 μl of ethanol to the control samples. Samples were mixed and incubated for 12 h, with occasional mixing. After incubation, samples were centrifuged (14,000 rpm, 15 min, at 21°C) and the hemozoin pellet repeatedly washed with 2%(wt/vol) SDS in 0.1 M sodium bicarbonate, pH 9.0, with sonication (30 min, at 21°C; FS100 bath sonicator; Decon Ultrasonics Ltd.) until the supernatant was clear (usually 3--4 times). After the final wash, the supernatant was removed and the pellet was resuspended in 1 ml of 0.1 M NaOH, incubated for an additional 1 h at room temperature. Afterwards, samples were mixed with a pipette. The hemozoin content was determined by measuring the absorbance at 400 nm (Beckmann DU640 spectrophotometer) using a 1-cm quartz cuvette. The amount of hemozoin formed during incubation was corrected for preformed hemozoin (the amount of preformed hemozoin in the parasite extract was determined from a sample containing extract, but no substrate, which was incubated and repeatedly washed with 2% SDS as previously stated). The concentration of drug required to produce 50% inhibition of polymerization (IC~50~) was determined graphically as described for the drug sensitivity assays.

Displacement of CQ Bound to FPIX-loaded Ghost Membranes and Parasite Debris
---------------------------------------------------------------------------

Erythrocyte ghost membranes were prepared as described previously ([@B22]). Membranes (0.27 mg protein) were loaded with FPIX (2--5 μM) in 0.2 M Hepes buffer, pH 7.0 (HB7) at 37°C for 7 min followed by centrifugation (14,000 rpm, 10 min). The supernatant was discarded and the pellet was washed once in HB7. Samples of FPIX-loaded membrane (0.01 mg protein) were suspended in 1 ml of HB7 containing 50 nM \[^3^H\]CQ and incubated in the absence or presence of various concentrations of the proteinase inhibitors, amiloride and the amiloride analogues EIPA, 5-*N*-*N*-hexamethylene amiloride (HMA), and 5-*N*-isobutyl-*N*-methyl amiloride (IBMA) for 10 min at 37°C. The membrane suspension was centrifuged (14,000 rpm, 2 min), the supernatant removed, and the pellet washed once in ice-cold HB7 without \[^3^H\]CQ. The remaining pellet was solubilized and processed for counting, as described above.

To measure CQ--FPIX binding affinity in a parasite-free system, the membranes were loaded in HB7 with 2 μM FPIX as above and samples (0.01 mg protein) were incubated in 1 ml HB7 containing 3 nM \[^3^H\]CQ and 5--10 μM nonradioactive CQ for 10 min at 37°C. The reaction was terminated by centrifugation and samples were processed as above. Nonspecific CQ binding was estimated from parallel incubation of FPIX-free membranes and subtracted from the total binding for each CQ concentration. Binding affinity was estimated by a computer fit of the data to the Michaelis-Menten equation. The displacement of preaccumulated \[^3^H\]CQ from parasite debris by EIPA was measured as described previously ([@B8]). Before lysis, erythrocytes infected with the CQS (HB3 strain) were loaded with 50 nM \[^3^H\]CQ in complete medium for 30 min at 37°C.

Cell-free Assay for the Generation of CQ Binding Sites from Hemoglobin
----------------------------------------------------------------------

Pure isolated food vacuoles were prepared by modifying the methods of [@B24] and [@B35]. Suspensions of synchronized trophozoites of the HB3 strain (∼15% parasitemia) were washed three times in PBS, pH 7.4. Each 5-ml sample of washed cell-pellet was resuspended in PBS containing 0.15% saponin, incubated for 5 min, and centrifuged (4,500 rpm for 5 min). The isolated trophozoites were washed repeatedly in ice-cold PBS until the supernatant was clear. The trophozoite pellet was collected and resuspended in 10 vol of ice-cold trituration buffer (0.25 M sucrose, 10 mM sodium phosphate, 0.5% streptomycin sulfate, pH 7.1) and triturated three times on ice, using a 27-gauge 3/4 in needle. The suspension was centrifuged (13,000 rpm, 2 min, at 4°C), supernatant discarded, and the pellet resuspended in 5 vol of buffer (2 mM magnesium sulfate, 100 mM potassium chloride, 10 mM sodium chloride, 25 mM Hepes, 25 mM sodium bicarbonate, 5 mM sodium phosphate, pH 7.1). To each 1 ml of the suspension 20 μl of 5 mg/ml DNaseI was added and the suspension was incubated at 25°C for 5 min, followed by centrifugation (13,000 rpm, 2 min, at 4°C). The supernatant was discarded and the pellet was resuspended in 5 vol of ice-cold trituration buffer and triturated once. The suspension was layered on top of 7 ml of ice-cold 42% Percoll solution containing 0.25 M sucrose, 1.5 mM magnesium chloride, pH 7.1, and centrifuged (12,000 rpm, 30 min, at 4°C). After centrifugation, the purified food vacuoles were harvested from the bottom of the gradient and washed three times in ice-cold buffer (0.25 M sucrose, 10 mM sodium phosphate, 1.5 mM magnesium chloride). Purity was checked by electron microscopy and by using assays of host cell and parasite cytosol marker enzymes as described previously ([@B35]). Electron microscopy revealed no contamination with other organelles or membranes and ∼50% of the vacuoles had intact membranes (data not shown). Contamination with the parasite cytosolic enzyme lactate dehydrogenase was \<0.7%. Compared with isolated trophozoites and contamination with host cell acetylcholine esterase was below the limits of detection in the assay.

Pellets of pure food vacuoles were added to 20 vol of ice-cold 500 mM sodium acetate, pH 5, and immediately subjected to five cycles of rapid freezing in liquid nitrogen and thawing at room temperature. The suspension was triturated 10 times with a 27-gauge needle and centrifuged (13,000 rpm, 3 min, 4°C). The proteinase-rich supernatant was collected and used for the cell-free assay. Protein content was measured using the bicinchoninic acid assay ([@B39]). Samples of the enzyme extract (2--10 μl) were added to 200 μl of 500 mM sodium acetate, pH 5, containing \[^3^H\]CQ or \[^3^H\]AQ. 100 μl of a 50-μM solution of human hemoglobin was added to the mixture. Purified erythrocyte ghost membranes (0.01 mg protein) were added to act as carriers for the CQ--FPIX complex. The samples were incubated for 1 h at 37°C in the absence or presence of 10 μM Ro 40-4388, or 20 μM Ro 61-7835, or 20 μM Ro 61-9379, or 20 μM leupeptin, or 20 μM E64. After incubation, the samples were centrifuged (14,000 rpm, 1 min) and the supernatant was removed gently with a drawn out glass Pasteur pipette to avoid disturbing the pellet. The pellet was washed once in ice-cold sodium acetate buffer without radiolabel and the remaining pellet was solubilized and processed for counting as described above.

Measurement of Parasite Cytosolic pH
------------------------------------

Parasite cytosolic pH was estimated using BCECF-AM as described by [@B47]. The parasite suspension preloaded with BCECF was incubated at 37°C for 15 min in a perfusion chamber and the cells were allowed to settle on a glass coverslip coated with poly-[l]{.smallcaps}-lysine. The experimental chamber was transferred to the stage of an inverted Diaphot microscope (Nikon). At appropriate time points, 10 μM Ro 40-4388, or 2 mM NH~4~Cl, or 2 mM methylamine was added to the perfusion buffer and the pH was monitored. NHE activity in sodium-free buffer was monitored by measuring the ability of the cell to recover from an acid load: the cells were perfused with Ringer\'s buffer containing 40 mM NH~4~Cl, after which the perfusion buffer was changed to Ringer\'s with one molar equivalent of choline replacing sodium. When the fall in cytoplasmic pH stabilized, the perfusion buffer was changed to sodium Ringer\'s to allow the cytosolic pH to recover.

Digital imaging microfluorimetry was carried out with an image analysis system (Quanticell 700 series; Applied Imaging International Ltd.) incorporating an intensified camera (CCD; Photonic Science). Background subtraction was performed independently for each excitation wavelength used. The autofluorescence of unloaded parasites was negligible. The excitation wavelengths used were 440 and 490 nm with emission measured above 510 nm. Calibration was performed for each cell using the nigericin/ high K^+^ method that uses two or three buffers of known pH ([@B47]). Since no ultrastructural detail could be observed under light microscopy, other than the food vacuole, the reported pH values are average values for the entire parasite cytosol minus the food vacuole.

Results {#Results}
=======

Saturable CQ Uptake in P. falciparum Is Driven by Binding to FPIX
-----------------------------------------------------------------

We determined the effect of a range of proteinase inhibitors on CQ uptake. In addition to Ro 40-4388, two other specific plasmepsin inhibitors, Ro 61-7835 and Ro 61-9379, inhibited CQ uptake at low micromolar concentrations (Fig. [1](#F1){ref-type="fig"} A). Similar inhibition was observed with the tripeptide aldehydes, ALLM and ALLN, which are known inhibitors of the processing of proplasmepsins I and II into active mature enzymes ([@B18]). The other cysteine proteinase inhibitors tested, E64 and leupeptin, were much less effective. Inhibition of proplasmepsin processing by the tripeptide aldehydes and the direct inhibition of the plasmepsins with Ro 40-4388 are reversible ([@B18]; Berry, C., personal communication). We have established that the inhibition of CQ uptake by both classes of compounds is also reversible, as predicted by our hypothesis (Fig. [1](#F1){ref-type="fig"}, B and C). In CQS parasites, CQ uptake is inhibited almost completely by the proteinase inhibitors (Fig. [1](#F1){ref-type="fig"}, A and B). In CQR parasites, the effect was smaller but the inhibition of the resistance reversing effect of verapamil was spectacular (Fig. [1](#F1){ref-type="fig"} C). This observation is in agreement with our hypothesis that verapamil increases CQ uptake by increasing the affinity of CQ--FPIX binding ([@B8]). Our data show that CQ--FPIX binding determines the amount of drug that is taken up by the parasite. The marked antagonism of CQ activity in the presence of Ro 40-4388 (Fig. [1](#F1){ref-type="fig"} D; [@B32]) suggests that binding to FPIX also determines the antimalarial activity of CQ.

Our model of the mechanism of CQ uptake is supported by the demonstration that proteinase inhibitors efficiently inhibit the degradation of hemoglobin and liberation of FPIX under the same conditions used to inhibit CQ uptake (Fig. [2](#F2){ref-type="fig"}). Hemoglobin digestion is almost completely inhibited by ALLM, ALLN, and Ro 40-4388. On the other hand, the effect of leupeptin was smaller. It is very difficult to accurately measure the concentration of free FPIX in parasites, so we have measured the concentration of hemozoin (polymerized FPIX). At the concentrations used, none of the compounds had any direct effect on the polymerization of FPIX in vitro (data not shown). However, all four compounds inhibited the production of hemozoin by intact parasites to some extent (Fig. [2](#F2){ref-type="fig"}). These data show that the concentration of FPIX is reduced when hemoglobin digestion is blocked. The inhibition was much more pronounced with ALLM, ALLN, and Ro 40-4388 than with leupeptin and was found to be reversible. Hemozoin production resumed at the normal rate when the proteinase inhibitors were removed by washing (Fig. [2](#F2){ref-type="fig"}). All these results are in agreement with the effect of the same inhibitors on CQ uptake (Fig. [1](#F1){ref-type="fig"}, A and B) and provide compelling evidence that CQ uptake results from binding of the drug to FPIX generated inside the infected erythrocyte.

The final piece of experimental evidence that proves the central role of FPIX binding in the uptake of CQ was obtained using a cell-free system. The binding characteristics of intact CQS parasites can be reconstituted using an erythrocyte ghost membrane preparation preloaded with FPIX. The capacity (B~max~) of saturable CQ binding to these membranes was dependent on the FPIX concentration, although at higher loading concentrations the apparent binding affinity was reduced due to aggregation of FPIX (data not shown). We measured an affinity (*K* ~d~) for this interaction of 25 nM (Fig. [3](#F3){ref-type="fig"} A). This value is the same as the apparent *K* ~d~ of saturable CQ uptake in CQS *P*. *falciparum*, again indicating that FPIX binding is all that is required to account for the saturable uptake of CQ ([@B8] and see below). Other experiments indicate that CQ binding sites can be generated from native hemoglobin by an extract from purified food vacuoles (Fig. [3](#F3){ref-type="fig"} B). There is little doubt that CQ binding is absent when either hemoglobin or vacuole extract is omitted, or when the extract has been heat-treated (data not shown). The same proteinase inhibitors that block the uptake of CQ into intact cells block CQ binding in the cell-free system (Fig. [3](#F3){ref-type="fig"} B). In fact, the percent inhibition of CQ binding in the cell-free system is almost perfectly correlated with the inhibition of CQ uptake into intact cells by similar concentrations of these compounds (R^2^ = 0.99, *P* \< 0.001). AQ binding sites can be generated in a similar fashion and have a similar inhibitor profile (Fig. [3](#F3){ref-type="fig"} C). These data suggest that the mechanism of AQ uptake is the same as that of CQ, i.e., the uptake of both drugs is driven by their binding to FPIX.

The initial rate of uptake of CQ into CQS parasites is rapid, prompting some authors to suggest that CQ is actively transported ([@B45]; [@B13]; [@B36]). However, our data suggest that the initial rate of CQ uptake is determined by the intraparasitic binding of CQ to FPIX rather than active transport. We found that after only a 5-min exposure of HB3 (CQS) parasites to CQ, the number of CQ binding sites (B~max~) was reduced from 17.2 μmol/liter to 6.9 μmol/liter by the specific hemoglobinase inhibitor Ro 40-4388 (Fig. [4](#F4){ref-type="fig"}).

The Uptake of CQ Is Independent of the Activity of the NHE
----------------------------------------------------------

In contrast to our explanation, others believe that CQ is transported through the NHE of CQS parasites ([@B36]; [@B47]). The NHE of CQR isolates was activated constitutively, incapable of CQ transport, and responsible for an elevated cytoplasmic pH ([@B47]). We were not able to reproduce these observations. In our hands, cytosolic pH is subject to a greater degree of variation and is actually lower in the resistant isolate (HB3, pH 7.183 ± SEM 0.04, *n* = 17; K1, pH 6.902 ± SEM 0.046, *n* = 12). The reason for this discrepancy is unknown but there may be a methodological basis: our pH measurements are average values for the whole cytosol (minus the food vacuole), whereas those of [@B47] refer to smaller regions of interest within the cytosol. Elevated cytoplasmic pH of CQR isolates is a fundamental tenet of the NHE hypothesis that probably does not apply to the isolates used in this study. Nonetheless, we have assessed the likely impact of small variations in cytosolic pH on the binding of CQ to FPIX. We found that the binding of CQ to FPIX in ghost membranes is sensitive to buffer pH, but this effect is probably not significant across the range of reported cytosolic pHs (Fig. [5](#F5){ref-type="fig"} A). We have also tested the effect of hemoglobinase inhibition on cytosolic pH although such an effect seems unlikely. We found that concentrations of Ro 40-4388, sufficient to block CQ uptake, had no effect on cytosolic pH, indicating that blocking hemoglobin degradation does not affect the cytosolic pH and that this compound does not block CQ uptake by interacting with the parasite NHE (Fig. [5](#F5){ref-type="fig"} B).

It is proposed that CQ is driven through the NHE of CQS parasites in a rapid burst of sodium-proton exchange stimulated by CQ itself ([@B47]). We tested this proposal directly by replacing the sodium ions in the media with nonexchangeable cations and monitoring the uptake of CQ into isolated parasites. This maneuver resulted in a marked inhibition of the NHE of isolated parasites, as evidenced by the inability to recover from an acid load (0.76 pH unit ± SEM 0.045, *n* = 6). It follows that sodium-free buffer should produce a very marked effect on CQ uptake if the NHE is involved in this process. It was observed that the initial rate of CQ uptake and steady-state CQ accumulation into isolated CQS parasites (HB3 strain) remained constant regardless of the concentration of sodium ions in the buffer (Fig. [6](#F6){ref-type="fig"}, A and B). These data demonstrate that CQ uptake is independent of the parasite\'s NHE activity status. The reported ability of CQ to stimulate the NHE of CQS parasites ([@B47]) is interesting but it appears to have no involvement in the mechanism of CQ uptake.

We also tested the effect of the sodium ion concentration on the uptake of CQ into isolated CQR parasites (K1 strain). The results, presented in Fig. [6](#F6){ref-type="fig"} C, again show that CQ uptake is unchanged when sodium ions are removed from the buffer. In addition, the reversal of CQ resistance by verapamil was independent of NHE activity, as it is retained in sodium-free medium (Fig. [6](#F6){ref-type="fig"} C). CQ accumulation of CQR parasites is reduced by a similar ratio compared with CQS parasites regardless of the sodium ion concentration. Moreover, it is independent of the presence or absence of the host cell (Fig. [6](#F6){ref-type="fig"}, A and C; [@B8]). Therefore, all of the phenotypic features of CQ uptake that distinguish CQR parasites from CQS parasites are retained in sodium-free medium thereby providing compelling evidence that the parasite NHE is not involved in CQ resistance.

Amiloride Derivatives Bind to FPIX and Displace CQ
--------------------------------------------------

EIPA significantly inhibits the uptake of CQ even though there are no sodium ions in the buffer and NHE is inactive (Fig. [6](#F6){ref-type="fig"}, A and B). These results are interesting because they indicate that EIPA inhibits CQ uptake by a mechanism distinct from the inhibition of NHE. One possibility is that EIPA inhibits the binding of CQ inside the parasite. This assessment is supported by the data presented in Fig. [7](#F7){ref-type="fig"}, showing EIPA displacing prebound CQ from parasite debris in a concentration-dependent manner. This interaction is not due to displacement of CQ bound to the NHE protein as this could only account for ∼5% of the measured CQ binding (calculated from binding data given in [@B36]).

Amiloride and its derivatives were shown to competitively inhibit the saturable uptake of CQ ([@B47]). Since we attribute saturable uptake of CQ to CQ--FPIX binding, we have looked for an interaction of these compounds with FPIX. Such an interaction is indicated by the data in Fig. [8](#F8){ref-type="fig"}, showing amilorides inhibiting FPIX polymerization. Indeed, HMA is almost as efficient an inhibitor of FPIX polymerization as CQ itself. These data suggest that amiloride derivatives might inhibit the uptake of CQ into *P*. *falciparum* by preventing CQ--FPIX binding. We tested this possibility directly and demonstrated that these compounds inhibit CQ--FPIX binding in loaded ghost membranes in a dose-dependent manner (Fig. [9](#F9){ref-type="fig"}). Interestingly, the 50% inhibitory concentration for EIPA was within the range reported for 50% inhibition of CQ uptake into *P*. *falciparum* by EIPA ([@B36]). Furthermore, the rank order of inhibition of CQ--FPIX binding by the amiloride analogues (HMA \> EIPA \> IBMA ≫ amiloride) is the same as the rank order of their inhibition of CQ uptake into intact parasitized erythrocytes ([@B47]). These data indicate that amiloride analogues do inhibit CQ uptake by blocking CQ--FPIX binding rather than inhibiting the parasite NHE. We also hypothesized that verapamil reverses CQ resistance by increasing the apparent affinity of CQ binding to FPIX ([@B8]). If our working model is correct and if EIPA binds to FPIX at the expense of CQ, then EIPA should ablate the verapamil effect; this is clearly demonstrated in Fig. [6](#F6){ref-type="fig"} C.

Lysosomotropic Compounds Selectively Increase the Apparent Affinity of CQ--FPIX Binding in CQR Isolates
-------------------------------------------------------------------------------------------------------

Although CQ is not actively transported through NHE (Fig. [6](#F6){ref-type="fig"}, A--C) it is still possible that CQ resistance may arise from changes in the cytosolic pH ([@B30]). Accordingly, we examined the effect of various agents known to perturb intracellular pH on the uptake of CQ by CQS and CQR parasites. We found that ammonium chloride, methylamine, a variety of alkylamines, and the carboxylic ionophores, monensin and nigericin, selectively increase the CQ accumulation of CQR parasites. The maximum effect was found at concentrations of 1--2 mM for amines and 100 nM for ionophores. In contrast, CQ accumulation by CQS parasites was either unaffected or reduced (Fig. [10](#F10){ref-type="fig"} A). In this respect, the amines and ionophores mimic the effect of verapamil ([@B27]). Ammonium chloride (Fig. [10](#F10){ref-type="fig"} B) and methylamine were also capable of reversing CQ resistance in the same way as verapamil (although the effect was not as pronounced). The remaining weak bases could not be assessed for their resistance reversal potential because of their inherent cytotoxicity.

Ammonium chloride, methylamine, and verapamil were selected to investigate the possibility that resistance reversers alter cytosolic pH of CQR parasites. We found that these compounds had no significant effect on cytosolic pH at the low concentrations required to reverse resistance (data not shown). Therefore, the ability of these compounds to increase CQ accumulation is unlikely caused by any interaction with cytosolic pH regulators like NHE. Indeed, any possible contribution of the NHE in the process of resistance reversal is negated by the data showing that ammonium chloride, monensin, and verapamil all increase the apparent affinity of CQ binding to FPIX in sodium-free medium, when the NHE is inactivated (Fig. [11](#F11){ref-type="fig"}, A--D).

We were also interested to see if any other cytosolic pH regulators could influence CQ uptake. In common with other eukaryotic cells, it is possible that *P*. *falciparum* parasites possess a chloride/bicarbonate exchange mechanism ([@B3]). If so, and if this protein can influence CQ uptake as suggested ([@B30]), then CQ uptake should be influenced by the bicarbonate concentration of the medium. It was found that CQ uptake into CQS and CQR parasites was not effected by the concentration of bicarbonate in the medium (Fig. [12](#F12){ref-type="fig"}). Taken together, our data suggest that none of the major cytosolic pH regulators play a major role in the uptake of CQ or in the mechanism of CQ resistance.

Discussion {#Discussion}
==========

The specificity of antimalarial activity of CQ stems from the potential of malaria parasites to accumulate more CQ than any other type of eukaryotic cell. CQR parasites of some species, including *P*. *falciparum*, have evolved ways to reduce the extent of CQ accumulation. A better understanding of the mechanism of CQ uptake in *P*. *falciparum* would be a significant step forward since it should explain the specificity of the drug and may also offer clues to the basis of resistance. CQ undoubtedly penetrates the parasite by passive diffusion as observed in other eukaryotic cells (MacIntyre and Cutler, 1993). CQ is a diprotic weak base and, as such, undoubtedly accumulates to some extent inside the acidic compartments of the parasite by a proton trapping mechanism ([@B48]). This mechanism may account for a considerable concentration of CQ inside cells ([@B20]). However, it probably does not account for the full extent of CQ accumulation by *P*. *falciparum*, which is notably greater than CQ accumulation by other eukaryotic cells with large acidic compartments (MacIntyre and Cutler, 1993). Pioneering studies by Fitch in the 1970s demonstrated that CQ uptake into *P*. *falciparum* is saturable, energy-dependent, and possibly inhibited by various compounds ([@B14]; [@B16]). These studies suggest that malaria parasites possess an additional CQ concentrating mechanism acting in concert with passive diffusion and proton trapping. Two putative CQ concentrating mechanisms are currently under consideration: active CQ import ([@B45]) mediated by the parasite NHE ([@B36]; [@B47]); and intracellular binding of CQ to FPIX ([@B9]; [@B8]).

The NHE hypothesis initially appears plausible and many of the supporting data are robust. However, a close scrutiny of the available literature reveals some intriguing inconsistencies that call into question the mechanistic explanation offered by [@B47]. Particularly problematic is the uptake of AQ, a close structural analogue of CQ. Early studies showed that AQ competitively inhibits the uptake of CQ in *P*. *falciparum*, suggesting that the same mechanism drives the uptake of both drugs ([@B16]). We reported that the uptake of AQ into CQR parasites is equivalent to the uptake of CQ into CQS parasites ([@B7]). It is hard to see how the extensive uptake of AQ into CQR parasites can be driven by an NHE that apparently is activated constitutively and incapable of drug transport ([@B47]).

A further difficulty is encountered when the effect of verapamil is considered. Many studies have highlighted the ability of verapamil to selectively increase the uptake of CQ into CQR parasites ([@B27]; [@B46]; [@B5]; [@B44]; [@B7]). Furthermore, this property of verapamil was linked perfectly to CQ resistance in the progeny of a genetic cross of CQR and CQS clones ([@B46]). If NHE is responsible for CQ uptake, then verapamil would somehow have to selectively stimulate NHE of resistant parasites that is constitutively activated and incapable of CQ transport. However, this is an unlikely scenario, doubly so, when one considers the large quantity of literature demonstrating verapamil functioning to inhibit rather than stimulate drug transporters and ion channels ([@B26]; [@B4]). The active transport model is inconsistent with our own data showing a role for CQ--FPIX binding in the uptake of CQ, in verapamil-sensitive CQ resistance and in the uptake of AQ ([@B8]). We rigorously tested these two hypotheses and found that the FPIX binding model remains valid, whereas the altered NHE model failed.

We have tested the assertion that a rapid burst of sodium--proton exchange is required to drive uptake of CQ into CQS parasites. We used isolated parasites for these experiments and assumed that NHE activity is not impaired under such conditions. We show here as others have shown that parasitic NHE is fully functional after the parasite has been isolated from its host cell ([@B3]). We found that replacing sodium ions in the buffer with nonexchangeable cations, such as choline or *[N]{.smallcaps}*-methyl-[d]{.smallcaps}-glucamine, inactivated NHE but had no effect on the amount of CQ taken up at steady-state by isolated CQS parasites (Fig. [6](#F6){ref-type="fig"} B). Moreover, sodium-free buffer had no effect on the initial velocity of CQ uptake into CQS parasites (Fig. [6](#F6){ref-type="fig"} A). This was measured over the first 5 min after the addition of CQ, which coincides with the reported period of maximal stimulated NHE activity ([@B47]). Since there can be no rapid burst of sodium--proton exchange in sodium-free buffer and CQ uptake is not altered by these conditions, our results strongly suggest that any ability of CQ to stimulate the NHE of CQS parasites ([@B47]) is unrelated to the mechanism of CQ uptake. In addition, we found that stimulation of CQ uptake into CQR parasites, produced by verapamil and other resistance reversers, was unrelated to the activity of the NHE because these effects are retained in sodium-free buffer (Figs. [6](#F6){ref-type="fig"} C and 11, A--D). Consequently, the effect of verapamil on the uptake of CQ cannot be attributed to modulation of NHE activity via the calcium-calmodulin regulatory pathway, as postulated by [@B36]. Hence, the clone-specific phenotypic characteristics of CQ uptake into CQS and CQR parasites are retained in conditions which completely inactivate the NHE (Figs. [6](#F6){ref-type="fig"}, A--C, and 11, A--D). Therefore, it is difficult to see how these characteristics can be related in any way to the activity of the parasite NHE.

We have demonstrated that amiloride analogue inhibition of CQ uptake occurs because of inhibition of CQ--FPIX binding by these compounds, rather than the inhibition of the parasite NHE. In a critical series of experiments, we were able to demonstrate that the inhibition of CQ uptake by EIPA was distinct from any activity of this drug against NHE. CQ uptake is undiminished in sodium-- free buffer when NHE is inactive, yet it is effectively inhibited when EIPA is present in this buffer (Fig. [6](#F6){ref-type="fig"}, A--C). These data strongly suggest that blocking CQ uptake by EIPA is caused by inhibition of a process that does not require sodium--proton exchange for CQ uptake. This directly violates the fundamental requirement of the NHE hypothesis.

There is solid experimental support for the FPIX model (Balsubramian et al., 1984; [@B41]; [@B8]). Therefore, the demonstration that EIPA displaces prebound CQ from parasite debris (Fig. [7](#F7){ref-type="fig"}), binds to FPIX (Fig. [8](#F8){ref-type="fig"}), and inhibits the binding of CQ to FPIX-loaded ghost membranes (Fig. [9](#F9){ref-type="fig"}) provides direct evidence that EIPA inhibits CQ uptake into parasites by binding to FPIX. Furthermore, the rank order of activity of the amiloride analogues (HMA \> EIPA \> IBMA ≫ amiloride) is the same for the inhibition of CQ--FPIX binding (Figs. [8](#F8){ref-type="fig"} and [9](#F9){ref-type="fig"}) as it is for the inhibition of CQ uptake ([@B47]). Examination of the chemical structure of amiloride reveals that either of the two terminal amino groups of the guanidine function has the potential to coordinate with the iron center of the porphyrin as an axial ligand (Rocha Gonslaves et al., 1991). Hoe 370, a specific NHE inhibitor that is structurally unrelated to the amiloride analogues, also has been shown to inhibit CQ uptake ([@B47]). Note, this compound also contains a guanidine function and may also bind to FPIX. Inhibition of CQ uptake by these specific NHE inhibitors provided the best evidence of active import of CQ through the NHE. However, in the light of the data reported here, we believe that this property of NHE inhibitors must now be considered to support the alternative theory that CQ uptake is governed by its binding to FPIX.

The central theme of the studies presented here is the definitive proof, after some thirty years of controversy, that saturable CQ uptake is driven by its binding to FPIX. We recently demonstrated that Ro 40-4388, a potent and specific inhibitor of the parasite proteolytic enzyme plasmepsin I ([@B32]), produces a concentration-dependent reduction in the number of CQ binding sites of intact parasitized erythrocytes ([@B8]). Here we have extended this observation blocking hemoglobin degradation by two distinct mechanisms. The plasmepsins are thought to initiate hemoglobin degradation by cutting the Phe33-Leu34 bond of the alpha chain. This unfolds the hemoglobin tetramer, allowing further proteolysis and the release of FPIX ([@B25]; [@B23]; [@B19]). Although the parasite contains other hemoglobinase enzymes, there is good evidence that the inhibition of plasmepsin I alone is sufficient to stop the digestion of hemoglobin and release of FPIX ([@B17], [@B19]). We have used Ro 40-4388, Ro 61-7835, and Ro 61-9379 to block hemoglobin cleavage. All three compounds are potent inhibitors of the parasite aspartic hemoglobinase enzymes, plasmepsin I and plasmepsin II ([@B32]; [@B8]; Moon, R.P., personal communication). In addition we have prevented proplasmepsin processing with ALLM and ALLN. We provide evidence that the reversible inhibition of CQ binding produced by Ro 40-4388 and other proteinase inhibitors stems from a reversible cessation of hemoglobin digestion and FPIX release in the parasite (Figs. [1](#F1){ref-type="fig"}, A--C, and 2).

Perhaps the most convincing support for our hypothesis comes from the demonstration that a purified food vacuole extract can generate CQ binding sites in a cell-free system using human hemoglobin as a substrate (Fig. [3](#F3){ref-type="fig"} B). The correlation of the inhibitor specificity of this process with that of CQ uptake into intact cells is compelling. Nevertheless, it is important that any proposed mechanism accounts quantitatively as well as qualitatively for CQ uptake. Further analysis of the data presented in Fig. [3](#F3){ref-type="fig"} B reveals that this is the case. The extract from 10^6^ vacuoles generates 123.72 fmol of CQ binding sites. At the external CQ concentration used (0.61 nM) this equates to a CAR of 2,399 (assuming one food vacuole per infected erythrocyte). This figure compares with a CAR of ∼2,600 for intact parasites under similar conditions (Fig. [1](#F1){ref-type="fig"} A). Much proteolytic activity has undoubtedly been lost in our assay because of poor enzyme extraction efficiency and leakage of enzymes from vacuoles during purification. Therefore, intact parasites clearly possess more than enough proteolytic activity to account for the uptake of CQ.

FPIX--CQ binding is the principal driving force for drug uptake including the initial CQ uptake kinetics, measured after 5 min exposure to CQ and previously attributed to a carrier-mediated import mechanism (Fig. [4](#F4){ref-type="fig"}). Published estimates of the rate of hemoglobin digestion adequately defend this argument. It is estimated that each parasite degrades 0.06 fmol of hemoglobin per hour ([@B24]). This would liberate 50 μmol FPIX per liter of parasites in 5 min, i.e., more than enough to account for initial rate of bound CQ (17.2 μmol per liter in 5 min, Fig. [4](#F4){ref-type="fig"}) even at a stoichiometry of 2 FPIX:1 CQ. If so, this indicates that CQ uptake may limit itself by stopping hemoglobin digestion since the steady-state B~max~ is only 30--40 μmol per liter ([@B8]). CQ uptake might be limited by CQ--FPIX inhibition of the hemoglobinase enzymes. It is possible that sufficient CQ--FPIX complex remains within the vacuole to inhibit the proteolytic enzymes (Vander Jagt et al., 1987; [@B23]).

To quote [@B9], "Unequivocal identification of an isolated substance as a drug receptor requires (a) that affinities and specificities of binding of the drug match those of the receptor, (b) that the drug is ineffective when the putative receptor is absent from the organism, and (c) that drug effectiveness returns when the receptor is reintroduced into the organism." The specificity of hemoglobinase inhibitors that inhibit cellular CQ uptake is identical to their specificity in the cell-free enzymatic CQ binding assay (Figs. [1](#F1){ref-type="fig"} A and 3 B). These drugs are specific and reversible inhibitors of FPIX generation (Fig. [2](#F2){ref-type="fig"}). This biochemical knockout has permitted us to show that FPIX can be reversibly removed, causing a reversible inhibition of drug uptake (Figs. [1](#F1){ref-type="fig"} B and 2). In addition to governing the uptake of the drug, CQ--FPIX binding determines antimalarial activity since the combination of CQ and hemoglobinase inhibitors is markedly antagonistic (Fig. [3](#F3){ref-type="fig"} C; [@B32]). Furthermore, we were able to match the affinity of binding of CQ to CQS parasites to the affinity of CQ--FPIX binding in a parasite-free system (Fig. [3](#F3){ref-type="fig"} A). Thus, all of the above criteria have been satisfied and identify FPIX as the CQ receptor in *P*. *falciparum*.

Our data indicate that NHE has no involvement in the mechanism of CQ resistance (Figs. [6](#F6){ref-type="fig"} and [11](#F11){ref-type="fig"}). Indeed, any involvement of cytosolic pH regulation seems unlikely. Instead, our data suggest that CQ resistance stems from an alteration in the local environment of FPIX generation in acid vesicles. We found that a wide range of lysosomotropic compounds mimics the effects of verapamil (Fig. [10](#F10){ref-type="fig"} A). This could indicate the inhibition of a drug transporter similar to P-glycoprotein. However, since many of these compounds are not known to interact with P-glycoprotein, we suggest an alternative mode of resistance reversal. The concentrations required to reverse resistance produced no alkalinization of the parasite cytosol but might be expected to produce a significant alkalinization of lysosomes and endosomes ([@B31]). There is evidence in the literature that hemoglobin digestion begins in hemoglobin delivery vesicles, before they fuse with the food vacuole ([@B38]). To protect the parasite, the resistance mechanism must be operational throughout the endocytic pathway. The intracellular localization of CQ resistance gene CG2 throughout the endocytic pathway is certainly consistent with this hypothesis ([@B40]). It is our belief that CQ resistance results from a selective change in vesicular function within relevant hemoglobin processing acidic compartments. This reduces the affinity of CQ--FPIX binding that can be reversed by lysosomotropic agents. CG2 and related proteins could potentially alter the binding of CQ to FPIX by directly binding to FPIX or by altering vesicular pH or buffering capacity. All of these mechanisms could be modulated by vesicle alkalinization and are currently under investigation in our laboratory.
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###### 

The effect of various proteinase inhibitors on the steady-state uptake (CAR) and activity of CQ. (A) The following inhibitors are shown: E64 (closed square); leupeptin (open circle); Ro 61-9379 (closed triangle); Ro 61-7835 (open square); ALLN (closed inverted triangle); ALLM (open inverted triangle); and Ro 40-4388 (closed circle). (B) The reversible effect of proteinase inhibitors on the steady-state accumulation of CQ by CQS (HB3) parasites. Control data without inhibitor are shown by light shaded bars. Dark shaded bars show the effect before and after wash-off of 10 μM Ro 40-4388, 20 μM ALLM, and 20 μM ALLN. (C) The effect of the same concentrations of proteinase inhibitors (pre-wash) on the steady-state accumulation of CQ by CQR (K1) parasites in the absence (light shaded bars) or presence (dark shaded bars) of 10 μM verapamil. The effect of the inhibitors is reversible on washout (post-wash). Data are means ± SD from 10 experiments. (D) Antagonism of Ro 40-4388 and CQ against the CQS (HB3) parasite.
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![Proteinase inhibitors reversibly inhibit the degradation of hemoglobin and the release of FPIX in *Plasmodium falciparum*. Cell suspensions were incubated for 3 h at 37°C in the absence or presence of 10 μM Ro 40-4388, 20 μM ALLM, 20 μM ALLN, or 20 μM leupeptin. Dark shaded bars show concentration of hemoglobin. Concentration of hemozoin is shown before inhibitor\'s washout (light shaded bars) and after washout with an additional 3-h incubation (unshaded bars). Percentage inhibition of hemoglobin digestion and hemozoin production are given above the bars. Data are means ± SD from five experiments.](JCB9807109.f2){#F2}

###### 

CQ binding to FPIX in cell-free systems. (A) Binding of CQ to FPIX-loaded ghost membranes. Membranes were preincubated with 2 μM FPIX, washed, incubated with 50 nM \[^3^H\]CQ for 10 min at 37°C and the amount of bound CQ determined. Derived *K* ~d~ = 24.7 ± 2.1 nM. Data are means ± SD from 10 experiments. (B) CQ binding produced by enzymatic activity of a food vacuole extract using human hemoglobin as a substrate. All inhibitors were used at 20 μM except Ro 40-4388 that was used at 10 μM. Data are means ± SEM from four separate experiments. (C) AQ binding produced by enzymatic activity of a food vacuole extract using human hemoglobin as a substrate. Inhibitor concentrations are the same as for CQ. Data are means ± SEM from four separate experiments.
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![The initial uptake of CQ is determined by binding to FPIX. Binding of CQ by CQS (HB3) parasites in the absence (open circle) or presence (closed circle) of 10 μM Ro 40-4388. In the absence of Ro 40-4388, the derived *K* ~d~ = 18.08 ± 2.88 nM and the derived capacity = 17.2 ± 2.82 μM. In the presence of Ro 40-4388, the derived *K* ~d~ = 17.45 ± 1.85 and the derived capacity = 6.93 ± 0.73 μM. Data points are means of duplicate observations from three separate experiments.](JCB9807109.f4){#F4}
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\(A\) The effect of buffer pH on CQ--FPIX binding in a ghost membrane system. Membranes were preincubated with 5 μM FPIX, washed, and incubated with 50 nM \[^3^H\]CQ for 10 min at 37°C. Afterwards, the amount of bound CQ was determined. Data are means ± SD from ten experiments. (B) The effect of Ro 40-4388 on the cytosolic pH of a single HB3 parasite. The proteinase inhibitor was added and washed out at the time points shown. Other arrows indicate the start points of a two-point pH calibration. Shown is a single representative trace from \>20 similar experiments.
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The uptake of CQ into isolated parasites is not affected by the buffer Na^+^ concentration. Cell suspensions were incubated with 50 nM \[^3^H\]CQ at 37°C and the amount of CQ taken up was determined at the indicated time points. (A) Initial velocity of CQ uptake into isolated CQS (HB3) parasites in buffer containing sodium (open circle), or choline (closed circle), or glucamine (open square), or choline plus 100 μM EIPA (closed triangle). Data points are means of duplicate observations. (B) Uptake of \[^3^H\]CQ into isolated CQS (HB3) parasites after 30 min at varying ratios of sodium ions to choline ions in the absence (light shading) and presence (dark shading) of 100 μM EIPA. Data are means ± SD from five experiments, each performed in duplicate. (C) Uptake of \[^3^H\]CQ into isolated CQR (K1) parasites after 30 min in the absence (light shading) and presence (dark shading) of 10 μM verapamil in buffer containing either sodium, choline, glucamine, or choline plus 100 μM EIPA. Data are means ± SD from five experiments, each performed in duplicate.
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![EIPA-dependent displacement of prebound CQ from cell debris from cells preloaded with \[^3^H\]CQ. Cell debris were exposed to EIPA (closed circle) at the concentrations indicated. Data are means ± SD from five experiments.](JCB9807109.f7){#F7}

![Inhibition of FPIX polymerization by CQ and amiloride analogues. Data are presented for CQ (open circle), HMA (closed inverted triangle), EIPA (closed triangle), and amiloride (closed circle). Data are means ± SD from three experiments.](JCB9807109.f8){#F8}

![Displacement of CQ bound to FPIX-loaded ghost membranes. Membranes were preincubated with 5 μM FPIX, washed, incubated with 50 nM \[^3^H\]CQ for 10 min at 37°C, and the amount of bound CQ determined. Data are presented for HMA (closed inverted triangle), EIPA (closed triangle), IBMA (closed square), and amiloride (closed circle). Data are means ± SD from 10 experiments.](JCB9807109.f9){#F9}

###### 

Clone-specific effects of resistance modulators on the uptake and activity of CQ in CQS and CQR *P*. *falciparum*. (A) CQ uptake data are presented for CQS (HB3) parasites (light shading) and CQR (K1) parasites (dark shading). Data are means ± SD from five experiments. (B) CQ activity data are presented for CQS (3D7) parasites in the absence (open circle) and presence (closed circle) of ammonium chloride and for CQR (K1) parasites in the absence (open square) and presence (closed square) of ammonium chloride and in the presence of verapamil (closed triangle). Data are means from three sensitivity assays, each performed in triplicate.
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###### 

Resistance modulators increase the apparent affinity of CQ binding to CQR parasites regardless of NHE activity. (A) The effect of substituting choline for sodium on the cytosolic pH of a single K1 (CQR) parasite in its host cell. Cells were preloaded with 40 mM ammonium chloride in sodium buffer. The arrows indicate subsequent perfusion with choline buffer followed by sodium buffer perfusion when acidification was complete. Shown is a single representative trace from 12 similar experiments. (B) CQ binding in choline buffer, in the absence (open circle) or presence (closed circle) of verapamil. (C) CQ binding in the absence (open circle) or presence (closed square) of monensin. (D) CQ binding in the absence (open circle) or presence (closed triangle) of ammonium chloride. Data points are means from three experiments.
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![Clone-specific CQ uptake characteristics are independent of the concentration of bicarbonate in the medium. Data are presented for the CQR (K1) clone (closed circle) and the CQS (HB3) clone (open circle). Data are means ± SD from five experiments.](JCB9807109.f12){#F12}
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